Primary Ovarian Insufficiency

On this page

Primary Ovarian Insufficiency - Ovarian Fade-Out

  • Depletion/dysfunction of ovarian follicles < 40 yrs. Leads to amenorrhea (≥4 months), hypoestrogenism, & persistently ↑FSH (>25-40 IU/L, measured twice >4 wks apart).
  • Etiology:
    • Idiopathic (most common)
    • Genetic: Turner syndrome (45,X0), Fragile X premutation (FMR1)
    • Autoimmune disorders (e.g., autoimmune oophoritis, thyroiditis)
    • Iatrogenic: Chemotherapy, radiotherapy, ovarian surgery
    • Environmental toxins, infections (mumps), galactosemia
  • Key Concerns: Infertility, osteoporosis, cardiovascular risks, psychological impact.
  • Management: HRT (estrogen + progestin until avg. age of menopause), calcium/Vit D. Fertility via oocyte donation.

⭐ Most common genetic causes of POI include Turner Syndrome (45,X0) and FMR1 gene premutation (Fragile X).

Primary Ovarian Insufficiency - Clues & Confirmation

  • Clinical Clues:
    • Age < 40 years
    • Menstrual dysfunction: Amenorrhea (secondary > primary) or oligomenorrhea (≥ 4 months)
    • Hypoestrogenic symptoms:
      • Vasomotor: Hot flushes, night sweats
      • Urogenital: Vaginal dryness, dyspareunia
      • Psychological: Mood swings, sleep disturbance
    • Infertility
  • Diagnostic Confirmation:
    • Biochemical (key):
      • ↑ Serum FSH > 25-40 IU/L (on 2 occasions, >4 weeks apart)
      • ↓ Serum Estradiol < 50 pg/mL
    • Etiological workup:
      • Karyotype: Rule out Turner (45,X), Y chromosome presence
      • FMR1 gene testing: For Fragile X premutation (esp. if family hx)
      • Autoimmune screening: TSH, anti-TPO Ab; consider anti-adrenal Ab
      • Ovarian reserve markers: ↓AMH, ↓Antral Follicle Count (AFC) on ultrasound

⭐ Karyotyping is crucial in all women with POI diagnosed before age 30 to detect Turner syndrome mosaics or Y chromosome material, which carries a risk of gonadoblastoma.

Primary Ovarian Insufficiency - Hormone Harmony & Hope

  • Hormone Replacement Therapy (HRT): Mainstay treatment.
    • Aims: Symptom relief (vasomotor, urogenital), bone protection, improved well-being.
    • Regimen (with uterus): Estrogen + Progestin.
      • Estrogen: e.g., Estradiol 1-2 mg/day (oral), 50-100 µg/day (transdermal).
      • Progestin: e.g., MPA 5-10 mg/day or micronized progesterone 200 mg/day, for 12-14 days/month.
    • Duration: Until median age of natural menopause (~51 years).
  • Fertility Management:
    • Spontaneous pregnancy: Rare (5-10%).
    • Oocyte donation: Best success.
    • Adoption.
  • Bone Health:
    • Calcium 1200 mg/day, Vitamin D 800-1000 IU/day.
    • Weight-bearing exercise. DEXA scan.
  • Psychosocial Support: Essential.
    • Counseling, support groups.

⭐ HRT in POI should continue until the average age of natural menopause (~51 years) to mitigate long-term risks like osteoporosis and cardiovascular issues.

Primary Ovarian Insufficiency - Ripple Effects

  • Infertility: Primary and often devastating consequence.
  • Bone Health: ↓ Estrogen leads to ↑ bone resorption, significantly ↑ osteoporosis risk.
    • Regular DEXA screening recommended.
  • Cardiovascular Disease (CVD): Premature estrogen loss ↑ risk of heart disease.
    • Monitor lipids, BP.
  • Psychological & Sexual: Mood disorders (depression, anxiety); vaginal atrophy, dyspareunia, ↓ libido.
  • Associated Autoimmune Disorders: Higher incidence of thyroiditis, Addison's.
  • Management Focus: HRT until natural menopause age (~51 yrs) to mitigate risks.

⭐ Untreated POI significantly increases risk of premature mortality, mainly from cardiovascular events and osteoporotic fractures.

High‑Yield Points - ⚡ Biggest Takeaways

  • Primary Ovarian Insufficiency (POI): Ovarian failure before age 40, with amenorrhea and menopausal symptoms.
  • Hormonal hallmarks: ↑FSH (>25-40 IU/L, repeat), ↑LH, ↓estradiol, ↓AMH.
  • Common causes: Idiopathic (often autoimmune); genetic (e.g., Turner syndrome, Fragile X premutation).
  • Essential workup: Karyotyping in women with POI diagnosed < age 30.
  • Major complications: Osteoporosis, cardiovascular disease, infertility, psychological distress.
  • Management: HRT until natural menopause age (~51 years); oocyte donation for fertility_._

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Primary Ovarian Insufficiency

  1. 1. Which serum level is increased in premature ovarian failure?

    • A. Serum Inhibin
    • B. Serum Estradiol
    • C. Serum Follitropin
    • D. Serum Progesterone
    Show answer

    Answer: C. Serum Follitropin

    Serum Follitropin - FSH rises when ovarian estrogen and inhibin production falls, because reduced negative feedback allows increased pituitary gonadotropin secretion. - In premature ovarian failure, the pituitary attempts to stimulate non-responsive ovaries, producing persistently elevated serum FSH. Serum Inhibin - Inhibin is produced by ovarian granulosa cells and normally suppresses pituitary FSH secretion through negative feedback. - With premature ovarian failure, ovarian dysfunction reduces inhibin production; therefore, serum inhibin is typically decreased rather than increased. Serum Progesterone - Progesterone is produced mainly by the corpus luteum after ovulation, so its level depends on functional ovulatory cycles. - Because premature ovarian failure commonly causes impaired or absent ovulation, serum progesterone is low or undetectable rather than increased. Serum Estradiol - Estradiol is the principal estrogen produced by the ovaries and normally contributes to negative feedback on pituitary gonadotropin secretion. - In premature ovarian failure, impaired ovarian function reduces estradiol production, so serum estradiol is decreased rather than increased.

  2. 2. A baby girl presents with bilateral inguinal masses, which are found to be testes in the inguinal canals. Which karyotype would you expect to find in the child?

    • A. 46, XY
    • B. 46, XX
    • C. 47, XYY
    • D. 47, XXY
    Show answer

    Answer: A. 46, XY

    46, XY - 46, XY indicates the presence of a Y chromosome and SRY-driven development of testes, which produce testosterone and anti-Müllerian hormone in androgen insensitivity syndrome. - A mutation in the androgen receptor prevents androgen action, producing female external genitalia while testes commonly remain undescended in the inguinal canals and Müllerian structures are absent. 46, XX - 46, XX is the usual female karyotype and would normally be associated with ovaries rather than testes in the inguinal canals. - Although an inguinal mass may occur in a girl through inguinal herniation, the demonstrated testes strongly indicate a Y chromosome–associated disorder such as AIS. 47, XYY - 47, XYY is associated with an additional Y chromosome and typically a phenotypic male presentation, not female external genitalia with inguinal testes. - The defining problem here is androgen receptor insensitivity, which is classically associated with 46, XY rather than XYY karyotype. 47, XXY - 47, XXY causes Klinefelter syndrome, typically characterized by a male phenotype, small firm testes, and possible gynecomastia rather than female external genitalia. - The presence of testes with female appearance in this case reflects androgen insensitivity, whose expected karyotype is 46, XY, not XXY.

  3. 3. Which laboratory finding is expected in an infant with failure to thrive, ambiguous genitalia, dehydration, hypotension and hyponatremia due to salt-wasting 21-hydroxylase deficiency?

    • A. High serum cortisol
    • B. High urinary sodium
    • C. Low serum potassium
    • D. Metabolic alkalosis
    Show answer

    Answer: B. High urinary sodium

    High urinary sodium - Deficient aldosterone causes reduced renal sodium reabsorption, producing increased urinary sodium loss with hyponatremia, dehydration, and hypotension. - This salt-wasting crisis also causes hyperkalemia because impaired mineralocorticoid action reduces potassium excretion, supporting the diagnosis. High serum cortisol - 21-hydroxylase deficiency impairs cortisol synthesis, so cortisol production is decreased rather than increased in salt-wasting congenital adrenal hyperplasia. - Reduced cortisol feedback increases ACTH, causing adrenal hyperplasia and androgen excess, but it does not restore cortisol production. Low serum potassium - Low serum potassium is incorrect because aldosterone deficiency reduces potassium secretion in the distal nephron, causing potassium retention. - Salt-wasting 21-hydroxylase deficiency characteristically produces hyperkalemia alongside hyponatremia, dehydration, and hypotension. Metabolic alkalosis - Metabolic alkalosis is not expected when mineralocorticoid activity is deficient, because reduced distal hydrogen-ion secretion favors acidosis. - Salt-wasting congenital adrenal hyperplasia typically causes metabolic acidosis, together with hyponatremia and hyperkalemia.

  4. 4. A Lethargic hypoglycemic girl neonate has the following genital appearance. What is the probable cause?

    • A. Congenital adrenal hyperplasia
    • B. Klinefelter syndrome
    • C. Ovotesticular disorder of sex development
    • D. Turner syndrome
    Show answer

    Answer: A. Congenital adrenal hyperplasia

    Congenital adrenal hyperplasia, most commonly due to 21-hydroxylase deficiency, explains virilized external genitalia and hypoglycaemia from cortisol deficiency. Associated aldosterone deficiency can cause salt wasting, but electrolyte loss is not established by this stem. Turner syndrome usually has female external genitalia without androgen-driven virilization and does not explain this adrenal presentation. Klinefelter syndrome generally has male external genitalia and does not cause this neonatal adrenal presentation. Ovotesticular disorder of sex development can cause atypical genitalia but does not typically cause cortisol deficiency with hypoglycaemia.

  5. 5. Resistance to Methotrexate develops due to?

    • A. Rapid proliferation of cancer cells
    • B. Thymidylate kinase deficiency
    • C. Thymidylate synthetase deficiency
    • D. Dihydrofolate reductase excess
    Show answer

    Answer: D. Dihydrofolate reductase excess

    Dihydrofolate reductase excess - Methotrexate inhibits dihydrofolate reductase (DHFR), reducing tetrahydrofolate availability for nucleotide synthesis and DNA replication. - Cancer-cell DHFR overproduction, often through gene amplification or overexpression, provides sufficient target enzyme to overcome inhibition and is a major resistance mechanism. Thymidylate kinase deficiency - Thymidylate kinase deficiency impairs conversion of dTMP toward dTDP and dTTP, disrupting DNA synthesis rather than reducing methotrexate’s inhibition of DHFR. - This deficiency is not a recognized principal mechanism of methotrexate resistance; altered DHFR quantity or function is the more useful distinguishing mechanism. Thymidylate synthetase deficiency - Thymidylate synthetase deficiency would reduce dTMP production and impair DNA synthesis, so it does not allow cells to bypass methotrexate’s action. - Although increased thymidylate synthetase expression can contribute to resistance, deficiency is not the mechanism described here and is less characteristic than DHFR overproduction. Rapid proliferation of cancer cells - Methotrexate is S-phase specific and inhibits DHFR, limiting folate-dependent nucleotide synthesis in dividing cells. - Rapidly proliferating cancer cells are generally more susceptible to effective methotrexate therapy, so proliferation alone does not explain acquired drug resistance.

  6. 6. Which hormone is known to be elevated in Polycystic Ovary Syndrome (PCOS)?

    • A. Progesterone
    • B. Follicle-stimulating hormone
    • C. Thyroid-stimulating hormone
    • D. Luteinizing hormone
    Show answer

    Answer: D. Luteinizing hormone

    Luteinizing hormone - Luteinizing hormone is often elevated in PCOS, producing an increased LH:FSH ratio characteristic of the disorder. - Increased luteinizing hormone stimulation promotes ovarian androgen production, contributing to anovulation and other PCOS features. Progesterone - Progesterone is commonly reduced in anovulatory PCOS because a functioning corpus luteum does not form. Follicle-stimulating hormone - Follicle-stimulating hormone is typically normal or relatively low in PCOS rather than elevated compared with luteinizing hormone. - Reduced relative follicle-stimulating hormone activity impairs follicular maturation, contributing to anovulation and polycystic ovarian morphology. Thyroid-stimulating hormone - Thyroid-stimulating hormone regulates thyroid function and is generally unrelated to the characteristic hormonal imbalance of PCOS. - Elevated thyroid-stimulating hormone suggests hypothyroidism, a distinct endocrine disorder that may coexist with PCOS but does not explain its typical pattern.

  7. 7. A 23-year-old woman presents for evaluation of a 7-month history of amenorrhea. Examination discloses bilateral galactorrhea and normal breast and pelvic examinations. Pregnancy test is negative. Which of the following classes of medication is a possible cause of her condition?

    • A. Phenothiazines
    • B. Prostaglandins
    • C. Antiestrogens
    • D. Gonadotropins
    Show answer

    Answer: A. Phenothiazines

    Phenothiazines - Phenothiazines block D2 dopamine receptors on anterior-pituitary lactotrophs, removing dopamine-mediated inhibition of prolactin secretion. - Raised prolactin suppresses pulsatile GnRH secretion, reducing FSH and LH and causing amenorrhea with galactorrhea. Gonadotropins - Gonadotropins stimulate the ovaries directly and are used for ovulation induction; they do not block dopamine or produce hyperprolactinemia. - Although gonadotropins may cause ovarian hyperstimulation syndrome, this does not explain the combination of galactorrhea and secondary amenorrhea. Prostaglandins - Prostaglandins are primarily used for cervical ripening, labor induction, or abortion and do not significantly disrupt the prolactin–dopamine axis. - They therefore do not explain hyperprolactinemia causing galactorrhea and secondary amenorrhea in this patient. Antiestrogens - Antiestrogens such as clomiphene block hypothalamic estrogen receptors, increasing GnRH, FSH, and LH to promote ovulation. - Because they enhance gonadotropin release rather than block dopamine, antiestrogens do not typically cause galactorrhea or hyperprolactinemic amenorrhea.

  8. 8. Which of the following is used as a surrogate for the endogenous LH surge in IVF?

    • A. HMG
    • B. HCG
    • C. GnRH
    • D. IGF
    Show answer

    Answer: B. HCG

    HCG directly activates LH/hCG receptors and is the conventional pharmacological surrogate for the endogenous LH surge, inducing final oocyte maturation; retrieval is typically performed 34–36 hours later. IGF modulates follicular responses to FSH but is not used as the maturation trigger. HMG provides FSH and LH activity for follicular stimulation and is not the standard final maturation trigger. GnRH does not directly activate LH receptors; a GnRH agonist can instead induce an endogenous gonadotropin surge in suitable IVF protocols, which is a different triggering mechanism.

  9. 9. A 35-year-old woman presents with 4 months of amenorrhea, increased FSH, LH, and decreased estrogen. What is the most likely diagnosis?

    • A. Functional hypothalamic amenorrhea
    • B. Intrauterine adhesions
    • C. Primary ovarian insufficiency
    • D. Polycystic ovary syndrome
    Show answer

    Answer: C. Primary ovarian insufficiency

    Primary ovarian insufficiency - Primary ovarian insufficiency fits amenorrhea before 40 years with high FSH and low estrogen, as seen in this 35-year-old woman. Functional hypothalamic amenorrhea - Functional hypothalamic amenorrhea produces low or inappropriately normal gonadotropins, unlike the elevated FSH and LH in this patient. Intrauterine adhesions - Intrauterine adhesions generally preserve ovarian hormone production and do not explain this patient's high FSH and low estrogen. Polycystic ovary syndrome - Polycystic ovary syndrome does not produce the high-FSH, low-estrogen pattern seen in this patient.

  10. 10. A 21-year-old woman presents with complaints of primary amenorrhea. Her height is 153 cm, and her weight is 51 kg. She has well-developed breasts. She has no pubic or axillary hair and no hirsutism. Which of the following is the most probable diagnosis?

    • A. Turner's syndrome
    • B. Stein-Leventhal syndrome
    • C. Premature ovarian failure
    • D. Complete androgen insensitivity syndrome
    Show answer

    Answer: D. Complete androgen insensitivity syndrome

    Complete androgen insensitivity syndrome - Complete androgen insensitivity syndrome causes primary amenorrhea with well-developed breasts but absent pubic and axillary hair because androgen receptors cannot respond to testosterone. - Affected individuals are typically 46,XY with a phenotypically female appearance, undescended testes, and a blind-ending vagina. Premature ovarian failure - Premature ovarian failure causes ovarian dysfunction before age 40 and may produce primary or secondary amenorrhea, but it does not explain the characteristic absent pubic and axillary hair. - The patient’s well-developed breasts indicate estrogen exposure, whereas premature ovarian failure typically causes estrogen deficiency and impaired breast development. Stein-Leventhal syndrome - Stein-Leventhal syndrome, or PCOS, usually causes oligomenorrhea or secondary amenorrhea rather than primary amenorrhea in a patient with absent pubic hair. - PCOS is commonly associated with hyperandrogenism, including hirsutism, acne, and often obesity; this patient has no hirsutism and lacks androgen-dependent hair. Turner's syndrome - Turner syndrome causes short stature and ovarian dysgenesis, leading to amenorrhea, but impaired ovarian estrogen production usually results in absent or poorly developed breasts. - The patient’s well-developed breasts and absent pubic or axillary hair are more characteristic of complete androgen insensitivity than Turner syndrome.

Flashcards: Primary Ovarian Insufficiency

  1. 1. disorder of sex development (DSD) is characterized by the presence of both ovarian and testicular tissue in the same individual

    Show answer

    Ovotesticular

  2. 2. In polycystic ovarian syndrome, excess androgen (from theca cells) is converted to _____ in _____ tissue, which inhibits _____ secretion from anterior pituitary

    Show answer

    estrone · adipose · FSH

  3. 3. Primary ovarian insufficiency is associated with _____ abnormalities, especially in those younger than _____

    Show answer

    chromosomal · 30

  4. 4. In a pre-menopausal woman with simple hyperplasia without atypia, management is done using

    Show answer

    progesterone rx

  5. 5. Polycystic ovarian syndrome is characterized by _____ LH and _____ FSH

    Show answer

    high · low

  6. 6. Not more than ovarian cysts are punctured/drilled in each ovary in polycystic ovary syndrome.

    Show answer

    four

  7. 7. _____ presents with enlarged, bilateral cystic ovaries

    Show answer

    Polycystic ovarian syndrome

  8. 8. In women, decreased levels of sex hormone-binding globulin (SHBG) causes _____ due to _____ free testosterone

    Show answer

    hirsutism · increased

  9. 9. The corpus luteum synthesizes _____ and _____

    Show answer

    estradiol · progesterone

  10. 10. If a Y chromosome is identified in a phenotypic female, laparoscopic prophylactic _____ is recommended at the time of diagnosis to eliminate the risk of _____

    Show answer

    gonadectomy · gonadoblastoma

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF